The best treatment for renal cancer bone metastasis

Kidney cancer is more common in men. The occurrence of kidney cancer is related to smoking and bad living and eating habits. In the late stage of kidney cancer, metastasis is common, and bone metastasis is the most common. Patients with bone metastasis of kidney cancer suffer from cancer pain and have a low quality of life. Is the treatment method for bone metastasis of kidney cancer effective? The following experts from the Kidney Hospital will introduce it to you.

For patients with renal cancer bone metastasis, local treatments such as surgery and radiotherapy to reduce tumor burden are almost ineffective. Chemotherapy cannot completely eliminate residual tumor cells. Chemotherapy is insensitive to tumor tissue cells, which are the root cause of recurrence. It has great toxic side effects and causes serious damage to the immune system and hematopoietic system. In recent years, cell immunotherapy has been widely used in the clinical treatment of various malignant tumors, and has significant therapeutic effects on adenoma and solid tumors. It can be combined with conventional therapies to make up for the defects of conventional therapies. It has good safety and no serious adverse reactions.

Cell immunotherapy can be used in combination with chemotherapy to treat bone metastasis of renal cancer. Chemotherapy is the main method for treating bone metastasis of renal cancer. Chemotherapy can reduce the tumor cell load systemically, but chemotherapy has toxic side effects. If its toxic side effects cannot be reduced, it is likely to cause liver and kidney failure in patients after receiving large doses of chemotherapy, which is extremely dangerous for patients. Cell immunotherapy can reduce the toxic side effects of chemotherapy, enhance the sensitivity of chemotherapy, and improve patients' tolerance to chemotherapy drugs. In addition, cell immunotherapy can resist the immunosuppressive effects of chemotherapy drugs and support immune reconstruction after bone marrow failure.

According to nephrologists, for patients who have not yet received chemotherapy, blood can be collected for CIK culture before chemotherapy, followed by chemotherapy, and CIK treatment can be performed 1-2 weeks after chemotherapy (in order to wait for the concentration of residual chemotherapy drugs in the blood to drop and prevent residual chemotherapy drugs from damaging CIK cells) (the matching of chemotherapy treatment time and CIK culture cycle should be considered, that is, CIK infusion time is exactly 1-2 weeks after chemotherapy). Patients who have received chemotherapy should have blood drawn after their blood routine returns to normal.

Experts advise patients that if you have symptoms of bone metastasis of renal cancer, you must go to a regular kidney hospital for treatment to avoid delaying the treatment. Finally, I sincerely wish all patients a speedy recovery.